Mylan Blasts Apotex Challenge To Generic Benicar Exclusivity
Mylan Pharmaceuticals Inc. Tuesday blasted Apotex Inc.'s attempt to strip it of its exclusive rights to market a generic version of Daiichi Sankyo Co. Ltd.'s hypertension drug Benicar, urging an Illinois...To view the full article, register now.
Already a subscriber? Click here to view full article